News & Recent Releases

CMS Administrator Dr. Mehmet Oz addressed the rising discussion around covering GLP-1 medications (like Ozempic and Wegovy) for weight loss under Medicare. Citing “a lot of action” in the space, Oz confirmed that a decision on whether to expand coverage for these high-cost treatments is imminent. Read or watch the video to hear his full comments on the future of this policy.

At Public Health Grand Rounds at the Aspen Institute on October 6, Dr. Mehmet Oz addressed the fallout of the government shutdown and stood by key Republican policy decisions. Learn his position on the expiring ACA subsidies, the future of Medicare Advantage audits despite a court setback, and his agency’s plan to implement controversial Medicaid work requirements. Click to read the six biggest policy revelations.

Photo by Katya Wanzer

The Neuroarts Academic Network, launched in September 2025, is a key part of the NeuroArts Blueprint Initiative. Building on a baseline of core principles and findings, the Blueprint lays out both a five-year strategy and a longer-term, narrative-shifting path to culture change based on five core recommendations. Read more by clicking on the image.

Last October, nearly 6,000 neuroscientists experienced the power of the arts firsthand when an improvisational singer led them in creating harmony from a cacophony of sound. This musical interlude, which activated flow states and synchronized the audience, was part of a lecture by Susan Magsamen, founder and executive director of the International Arts + Mind Lab (IAM Lab).

A new groundbreaking report by Deloitte Canada quantifies the economic benefit of improved quality of life for Alzheimer’s patients and their caregivers—showing a $2.40 return for every $1 invested annually.